Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edmond

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Journal of Inherited Metabolic Disease|June 22, 2012
Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experienceDaniel H Wiseman, Jean Mercer, Karen Tylee, et al.
Journal of Inherited Metabolic Disease|January 22, 2011
Growth, final height and endocrine sequelae in a UK population of patients with Hurler syndrome (MPS1H)Chris J Gardner, Nicola Robinson, Tim Meadows, et al.
The Journal of Heart Valve Disease|June 30, 2004
Thrombotic risk in patients with aortic bioprosthesesJ J Edmond, S C Greaves, J K French, et al.
JIMD Reports|December 8, 2017
Haematopoietic Stem Cell Transplantation Arrests the Progression of Neurodegenerative Disease in Late-Onset Tay-Sachs DiseaseKarolina M Stepien, Su Han Lum, J Edmond Wraith, et al.
The Journal of Biological Chemistry|December 5, 1986
Regulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A synthase and the chromosomal localization of the human geneM Mehrabian, K A Callaway, C F Clarke, et al.
European Journal of Pediatrics|November 27, 2007
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyJ Edmond Wraith, Maurizio Scarpa, Michael Beck, et al.
The American Journal of Cardiology|March 28, 2006
Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaquesJohn J Edmond, John K French, Ralph A H Stewart, et al.
The Journal of Biological Chemistry|November 1, 2014
Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis IH Angharad Watson, Rebecca J Holley, Kia J Langford-Smith, et al.
Molecular Genetics and Metabolism|March 6, 2007
The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type IGregory M Pastores, Pamela Arn, Michael Beck, et al.
Pediatrics|January 2, 2009
Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis ILorne A Clarke, J Edmond Wraith, Michael Beck, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Journal of Inherited Metabolic Disease|June 22, 2012
Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experienceDaniel H Wiseman, Jean Mercer, Karen Tylee, et al.
Journal of Inherited Metabolic Disease|January 22, 2011
Growth, final height and endocrine sequelae in a UK population of patients with Hurler syndrome (MPS1H)Chris J Gardner, Nicola Robinson, Tim Meadows, et al.
The Journal of Heart Valve Disease|June 30, 2004
Thrombotic risk in patients with aortic bioprosthesesJ J Edmond, S C Greaves, J K French, et al.
JIMD Reports|December 8, 2017
Haematopoietic Stem Cell Transplantation Arrests the Progression of Neurodegenerative Disease in Late-Onset Tay-Sachs DiseaseKarolina M Stepien, Su Han Lum, J Edmond Wraith, et al.
The Journal of Biological Chemistry|December 5, 1986
Regulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A synthase and the chromosomal localization of the human geneM Mehrabian, K A Callaway, C F Clarke, et al.
European Journal of Pediatrics|November 27, 2007
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyJ Edmond Wraith, Maurizio Scarpa, Michael Beck, et al.
The American Journal of Cardiology|March 28, 2006
Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaquesJohn J Edmond, John K French, Ralph A H Stewart, et al.
The Journal of Biological Chemistry|November 1, 2014
Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis IH Angharad Watson, Rebecca J Holley, Kia J Langford-Smith, et al.
Molecular Genetics and Metabolism|March 6, 2007
The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type IGregory M Pastores, Pamela Arn, Michael Beck, et al.
Pediatrics|January 2, 2009
Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis ILorne A Clarke, J Edmond Wraith, Michael Beck, et al.
Pageof 11